The European Prostate Cancer Awareness Day (EPAD) aims to raise awareness and enhance knowledge of prostate cancer. Oncology specialists, patient advocates, politicians and policymakers gathered for EPAD20 online and in Brussels on 17 November 2020. I missed the live event but have been catching up with their videos/presentations. Some of the findings that I found interesting are below - scribbled notes as I tuned into these talks - big thanks to EPAD for letting people living with cancer join.
- Data from pre-PSA era show that PCa is a disease often related to a lot of suffering over a considerable period
- 2 out of 3 men diagnosed with PCa died of their disease
- Organized screening with the use of the PSA test reduces suffering and dying from PCa
- Potential harms ( unnecessary testing /over diagnosis and over treatment) can be largely avoided
EUPROMS study - some surprises re quality of life after treatment
Sexual function; there was slightly more impact with radiotherapy than radical prostatectomy - both treatments impacted significantly but this research flies contrary previous thoughts that prostatectomy had worse outcomes re sexual function. Of huge concern was the overall some 28% have a big problem and 22% a moderate problem ie 50%!
The conclusion is that early detection is key and that active surveillance should be considered as the first treatment in order to ensure the best quality of life.
The Awareness Day also heard from November and their campaigns to raise awareness about early detection - see more re UK branch at: https://uk.movember.com/